Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortality

被引:12
|
作者
Henao-Martinez, Andres F. [1 ,5 ]
Corbisiero, Michaele Francesco [1 ]
Salter, Ixchel [1 ]
Chastain, Daniel B. [2 ]
Thompson III, George R. [3 ,4 ]
机构
[1] Univ Colorado, Dept Med, Div Infect Dis, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Georgia, Dept Clin & Adm Pharm, Coll Pharm, Albany, GA 31701 USA
[3] Univ Calif Sacramento, Davis Med Ctr, Dept Med, Div Infect Dis, Sacramento, CA 95817 USA
[4] Univ Calif Sacramento, Davis Med Ctr, Dept Med Microbiol & Immunol, Sacramento, CA 95817 USA
[5] Univ Colorado, Anschutz Med Campus, 12700,19th Ave,Mail Stop B168, Aurora, CO 80045 USA
关键词
Aspergillus; invasive pulmonary aspergillosis; mortality; drug therapy; VORICONAZOLE; INFECTIONS; DIAGNOSIS; PHASE-3;
D O I
10.1093/mmy/myad074
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Invasive pulmonary aspergillosis (IPA) is a severe fungal infection that primarily affects immunocompromised patients and is associated with high mortality. Contemporary clinical characteristics of IPA and "real-world" estimates and predictors of associated mortality are inadequate. TriNetX, a global research network, was queried to identify adult patients with IPA diagnoses based on the ICD-10 code B44.0. We performed a propensity score-matched analysis comparing clinical characteristics among patients who survived versus non-survivors at 1 year. We identified 4371 patients with IPA. We found neoplasms, solid organ transplant recipients, hematologic malignancies, and aplastic anemia as the most predominant risk factors. The overall 1-year mortality was 32% for IPA. 1-year mortality was highest for patients with COVID-19 in the ICU, followed by those with acute myeloid leukemia and aplastic anemia (54%, 50%, and 39%, respectively). After propensity score matching, severe sepsis, pleural effusion, and candidiasis were mortality contributors within a year after diagnosis. Liver injury, systemic glucocorticoid exposure over the previous 6 months, lower lymphocyte and CD4 counts, elevated ferritin, LDH, thrombocytopenia, anemia, or elevated glycosylated hemoglobin (HbA1c) were independent predictors of mortality at 1 year. Voriconazole was the most common treatment (67%). The annual incidence of IPA was 0.001%, increasing to 0.02% among critically ill patients in the ICU. IPA continues to have a very high mortality. We encourage prospective studies to validate and refine the identified clinical markers linked to increased mortality. Lay Summary Invasive pulmonary aspergillosis (IPA) is common among immunocompromised patients. Analyzing a global research network, we found 32% of patients with IPA died a year after diagnosis. We identified the primary underlying conditions, contributors, and predictors of mortality.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Epidemiology and risk factors associated with gout control among adult Asians: a real-world retrospective cohort study
    Oka, Prawira
    Chong, Wei Ming
    Ng, Ding Xuan
    Aau, Wai Keong
    Tan, Ngiap Chuan
    FRONTIERS IN MEDICINE, 2023, 10
  • [42] Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis
    Narvaez, Javier
    Aguilar-Coll, Marti
    Vicens-Zygmunt, Vanesa
    Alegre, Juan Jose
    Bermudo, Guadalupe
    Molina-Molina, Maria
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [43] COVID-19-related acute invasive fungal rhinosinusitis: risk factors associated with mortality
    Ebied, Kamal
    Yacoub, Abraam
    Gamea, Mohamed
    Mahmoud, Mohammad Salah
    EGYPTIAN JOURNAL OF OTOLARYNGOLOGY, 2022, 38 (01)
  • [44] MORTALITY AND ITS RISK FACTORS AMONG IN-PATIENTS WITH INVASIVE ASPERGILLOSIS TREATED WITH VORICONAZOLE
    Ratidet, Jeeranan
    Sawangfah, Juntima
    Sakulwilailerd, Manasanan
    Siriyakorn, Nirada
    Kanchanasurakit, Sukrit
    Prawang, Abhisit
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2022, 53 (02) : 142 - 150
  • [45] Investigation of risk factors for invasive pulmonary aspergillosis among patients with COVID-19
    Song, Li
    Qiu, Ling
    Wang, Gang
    Zou, Wenlu
    Zhang, Shilong
    Sai, Lintao
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [46] Is Behcet's syndrome associated with an increased risk of ischemic heart disease? A real-world evidence in Taiwan
    Lin, Chun-Yu
    Chen, Hung-An
    Wu, Chun-Hsin
    Su, Yu-Jih
    Hsu, Tsai-Ching
    Hsu, Chung-Yuan
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [47] Clinical Characteristics and Prognostic Risk Factors of Patients With Proven Invasive Pulmonary Aspergillosis: A Single-Institution Retrospective Study
    Tong, Xiang
    Liu, Tao
    Jiang, Kexin
    Wang, Dongguang
    Liu, Sitong
    Wang, Ye
    Fan, Hong
    FRONTIERS IN MEDICINE, 2021, 8
  • [48] Clinical factors associated with invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: analysis of a 6-year clinical experience
    Wang, Huan
    Luo, Miao
    Fisher, David
    Pronyuk, Khrystyna
    Musabaev, Erkin
    Thu, Hien Nguyen Thi
    Ye, Pian
    Zhao, Lei
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [49] Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan
    Akram, Waqas
    Ejaz, Muhammad Bilal
    Mallhi, Tauqeer Hussain
    Sulaiman, Syed Azhar bin Syed
    Khan, Amer Hayat
    PLOS ONE, 2021, 16 (11):
  • [50] Insulin Therapy Is Associated With an Increased Risk of Carotid Plaque in Type 2 Diabetes: A Real-World Study
    Ke, Jiang-Feng
    Wang, Jun-Wei
    Zhang, Zhi-Hui
    Chen, Ming-Yun
    Lu, Jun-Xi
    Li, Lian-Xi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8